nad+ (injectable/iv)
DINUCLEOTIDE COENZYME - NOT A PEPTIDE
also: NAD+ · NAD · beta-NAD
NAD+ is a dinucleotide coenzyme, not a peptide, and injectable or intravenous NAD+ is a distinct proposition from the oral precursors nicotinamide riboside and nicotinamide mononucleotide that carry most of the published randomised evidence. Human data on IV NAD+ amount to small pilot studies showing that it does raise circulating NAD+ metabolites but is slow and unpleasant to infuse compared with an infused precursor.
// our evidence grade — unedited
Injected NAD+ itself has only small pilot human studies with a poor tolerability profile relative to alternatives, and the substantial randomised human literature people cite for it actually belongs to oral precursors, not to IV NAD+.
We grade this compound and we sell it. The grade is set against our published criteria before any stocking decision and is not adjusted because it is in the catalogue.
read the full evidence →// specification
| full name | Nicotinamide adenine dinucleotide, injectable and intravenous forms |
| cas | 53-84-9 |
| formula | C21H27N7O14P2 |
| molar mass | 663.43 g/mol |
| purity | ≥ 99% HPLC |
| form | lyophilised powder, sealed vial |
| storage | Reference-grade NAD+ free acid is a crystalline solid specified for storage at -20C, protected from moisture; it is hygroscopic and hydrolytically unstable in neutral to alkaline aqueous solution, so solutions are prepared fresh. |
| solubility | Freely water-soluble; reference material dissolves in PBS at pH 7.2 at approximately 10 mg/mL, and much higher concentrations are achievable in water. |
// select size
crypto payment · research use only · not for human consumption
// others in Longevity